- SRAX held first-ever virtual Sequire Cannabis Conference on April 20, 2021
- Event featured over 40 cannabis company presentations, keynote appearances by Steve DeAngelo, Dr. Sue Sisley, Emily Paxhia, Steven Hawkins, Dr. Jeffrey Chen
- Sequire provides data analytics tools that help public companies track investor activity, such as investor tracking, warrant management, shareholder surveys
- Sequire has grown to over 3 million users across 183 companies since 2019
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, recently held its first-ever virtual Sequire Cannabis Conference on April 20, 2021 (https://ibn.fm/nr7Pd). Nearly one million active small-cap investors were invited to the event, which featured presentations by over 40 cannabis companies along with keynote appearances by prominent industry experts such as Steve DeAngelo, Dr. Sue Sisley, Emily Paxhia, Steven Hawkins, and Dr. Jeffrey Chen.
The cannabis industry has undergone seismic shifts in the last decade that included the publication of notable scientific studies and extensive research reviews (https://ibn.fm/GbwCt), along with legalization in several states (https://ibn.fm/dT9BO). The industry has since exploded with thousands of new companies in various sectors, including plant genetics cultivation, product development, e-commerce portals and physical dispensaries across the United States.
Presenting at the Cannabis Conference were prominent industry leaders such as Steve DeAngelo, a lifelong activist, entrepreneur and co-founder of Harborside, The Arcview Group, The Last Prisoner Project non-profit organization, and the Radio Free Cannabis podcast. He was interviewed by Emily Paxhia, an investment expert who has reviewed thousands of companies in the cannabis space in addition to working with numerous founders in various capacities.
Also featured at the conference were interviews with Dr. Sue Sisley and Steve Hawkinsby Dr. Jeff Chen, co-founder and CEO of Radicle Science, and Founder and Director of the UCLA Cannabis Research Initiative. Sisley is an Arizona-based physician, President of Scottsdale Research, and Principal Investigator for FDA-approved randomized controlled trials. Hawkins is the President & CEO of the United States Cannabis Council and Executive Director of the Marijuana Policy Project.
The Cannabis Conference is one of many industry-specific events SRAX plans to host on Sequire this year. Besides event management, the platform empowers public companies with data analytics tools that include investor tracking, warrant management, and shareholder surveys. Since its 2019 inception, the platform has grown to include over 3 million users across 183 public companies and is rapidly becoming the premier analytics platform in the investment space (https://ibn.fm/jBwJf).
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels.
Replays of SRAX’s Sequire Cannabis Conference can be accessed at https://cannabis-conference.mysequire.com/.
For more information, visit the company’s websites at www.SRAX.com and www.MySequire.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
